baber/WOPTO huggingface dataset:
Patent AU-771867-B2 (AU)
Title: Chaperonin 10 and beta-interferon therapy of multiple sclerosis
Inventor: MORTON HALLE
IPC: A61P25/28
Filed: 2000-01-20
Granted: 2004-04-01
Abstract: A method of treating multiple sclerosis (MS) is provided which includes the step of administering a pharmaceutically-effective amount of chaperonin 10 and IFN-beta. Also provided are pharmaceutical compositions and a kit for treating MS, which include chaperonin 10 and IFN-beta.
Patent AU-753331-B2 (AU)
Title: Assay for specific strains of multiple disease related conformations of a protein
Inventor: PRUSINER STANLEY B
IPC: G01N33/566
Filed: 1999-02-05
Granted: 2002-10-17
Abstract: Assay methodology of the invention allows for: (1) determining if a sample contains a conformation of a protein which is associated with disease and the concentration and amount of such if present; (2) determining the amount of proteas resistant disease related protein in a sample and by subtracting that amount from the total amount of a disease related protein present determining the amount of protease sensitive disease protein in the sample; and (3) determining the strain and incubation time of a disease related protein by (i) relating the relative amounts of protease resistant and protease sensitive protein to known strains to thereby determine the strain; and (ii) plotting the concentration of protease sensitive protein on a graph of incubation time versus concentration of protease sensitive protein for known strains to predict the incubation time of an unknown strain of protein in a sample.
Patent AU-715127-B2 (AU)
Title: Portable radio telephone
Inventor: FEISSEL SOPHIE
IPC: H04N1/00
Filed: 1997-04-25
Granted: 2000-01-20
Abstract: Telephone comprising a radio unit (2) which can receive and provide on two sides analog signals and digital data, a corrector unit (3), a data processing unit (100) comprising a rate adaptor (8) and a fax adaptor (9), input means (14), a control unit (7), the data processing unit (100) and additionally a fax data memory (1,1, 16), the control unit (7) being arranged to control at least one of the two emission and reception functions of said fax data.
Patent AU-748492-B2 (AU)
Title: Electrically conductive microcapillary composite matrix and method for producing same
Inventor: SCHWARZ WOLFGANG
IPC: C04B28/24
Filed: 1999-03-08
Granted: 2002-06-06
Abstract: Microcapillary composite matrix consists of an electroconductive paint or coating on mortar or cement concrete on the surface layer of the concrete. The fraction of capillaries with a diameter \~ 50 nm is over 25%, preferably over 35% and higher than the fraction of microcapillaries to the total capillary porosity of the underlying concrete or mortar. The microcapillaries are interconnected and form a network with the capillary network in the concrete. The matrix has high ion conductivity, is resistant to weak acids and has a resistivity less than 25, preferably less than 5 ohm/cm. Its negative pore water pressure is higher than that in the concrete or mortar.  An Independent claim is also included for the production of the matrix by applying a suitable paint.
Patent AU-658262-B2 (AU)
Title: Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicaments containing them
Inventor: LANG HANS-JOCHEN
IPC: A61P9/00
Filed: 1993-02-12
Granted: 1995-04-06
Abstract: Ortho-substituted benzoylguanidines of the formula I <IMAGE>  where: R(1) is equal to halogen, alkyl, -X-R(6), where X is equal to O, S, NR(7) or Y-ZO and R(6) is equal to H, (cyclo)(halo)alkyl(methyl), -CnH2n-phenyl, R(3) is equal to H, -X-R(6), R(2) and R(4) are equal to R(11)-SO1-2-, (di)-alkyl-N-SO2-, or one of the two radicals R(2) or R(4) is equal to hydrogen or is defined as R(1), R(5) is equal to H, methyl, F, Cl, methoxy,  and their pharmaceutically acceptable salts.  They are obtained by a process in which compounds of the formula II <IMAGE> in which R(1) to R(5) have the meaning mentioned and L represents a leaving group which can be easily substituted nucleophilically, are reacted with guanidine. The compounds I are used for producing a medicament for the treatment and the prophylaxis of heart-rhythm disorders and ischaemically induced damage, as well as for producing a medicament for the inhibition of cell proliferation.
Patent AU-566598-B2 (AU)
Title: Dishwahing compositions containing layered clay
Inventor: GOEDHART MACHIEL
IPC: C11D3/12
Filed: 1984-10-17
Granted: 1987-10-22
Abstract: The use of a layered clay, e.g. a synthetic hectorite, in a non-enzymatic machine dishwashing composition provides for a significant reduction of spot and film formation.
Patent AU-733659-B2 (AU)
Title: Transaction card
Inventor: RAADSEN FERDINAND JAN ANTON
IPC: G07F1/06
Filed: 1997-08-15
Granted: 2001-05-17
Abstract: A gift token has a card-like handy body member with an appropriate imprint and representing a certain exchange-value which is exchangeable for a chosen good. The body member includes an integrated circuit with an electronically readable and programmable memory, intended for the storage (at least temporarily) of the above-mentioned exchange value, in a way which is compatible with an existing electronic payment system.
Patent AU-623932-B2 (AU)
Title: Stable oxapenem-3-carboxylic acids and their use as b-lactamase inhibitors
Inventor: PFAENDLER HANS-RUDOLF
IPC: C07D503/00
Filed: 1989-09-27
Granted: 1992-05-28
Abstract: The invention relates to the use of 1-oxapenem-3-carboxylic acids of the following structures 
<IMAGE>
 and
 in which R<1> and R<2> have the meaning given in the description, as  beta -lactamase inhibitors and to pharmaceutical compositions which contain the abovementioned 1-oxapenem-3-carboxylic acids and a conventional antibiotic.
Patent AU-663963-B2 (AU)
Title: Portable ultrasonic microspraying device
Inventor: HAUSER JEAN-LUC
IPC: B05B17/06
Filed: 1993-04-28
Granted: 1995-10-26
Abstract: PCT No. PCT/FR93/00411 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed Apr. 28, 1993 PCT Pub. No. WO93/22068 PCT Pub. Date Nov. 11, 1993.An acoustic micropulverization device for the formation of microdroplets is disclosed having a cell that contains a propagating medium having an attenuation less than or equal to about 1 dB/cm. One wall of the cell comprises an ultrasonic generator. Another wall of the cell contains a reflective surface that operates to focus ultrasonic waves upward toward a point that is near the top surface of a liquid that is contained in a reservoir located above the cell, thereby producing microdroplets above the liquid's top surface. A chamber is located over the top surface of the liquid. This chamber includes means for diffusing the microdroplets.
Patent AU-626603-B2 (AU)
Title: Thermoplastic molding composition of aromatic polycarbonate, aromatic polyester and copolymer of co/ethylene and process for preparing the same
Inventor: FARAH HANI
IPC: C08L73/00
Filed: 1989-11-06
Granted: 1992-08-06
Abstract: Environmental stress failure resistant and impact resistant polycarbonate blends are prepared from an aromatic polycarbonate, an aromatic polyester, and a copolymer of ethylene and carbon monoxide. These blends exhibit high impact resistance, chemical resistance, temperature stability and excellent thermoplastic engineering properties, making them particularly suitable for producing molded plastic components for the automotive and electrical housing manufacturing industries.
Patent AU-681345-B2 (AU)
Title: 3-aryl-pyrone derivatives
Inventor: FISCHER REINER
IPC: C07D309/38
Filed: 1993-08-25
Granted: 1997-08-28
Abstract: The invention relates to 3-arylpyrone derivatives of the general formula (I) <IMAGE>  in which   A represents hydrogen, halogen, optionally substituted radicals from the series comprising alkyl, cycloalkyl, alkenyl, alkynyl, arylalkyl, aryl, hetarylalkyl and hetaryl, or the groups -COR<1>, -COR2R<1>, -CN, -CONR<1>R<2>, -SO2R<1> and -P(O)(OR<1>)(OR<2>) in which   R<1> and R<2> independently of one another represent hydrogen or optionally substituted radicals from the series comprising alkyl, alkenyl, arylalkyl, aryl, hetarylalkyl and hetaryl or R<1> and R<2> together represent an optionally substituted alkylene group which can be interrupted by one or more hetero atoms;   B represents hydrogen or optionally substituted radicals from the series comprising alkyl, cycloalkyl, alkenyl, alkynyl, arylalkyl, aryl, hetarylalkyl and hetaryl; A and B together form an optionally substituted alkylene or alkenylene group which can be interrupted by, or contain, one or more hetero atoms or hetero groups;   X represents halogen, alkyl or alkoxy;   Y represents hydrogen, halogen, alkyl, haloalkyl or alkoxy;   Z represents hydrogen, halogen, alkyl or alkoxy;   n represents an integer 1, 2 or 3; and G represents hydrogen, a metal ion equivalent and an ammonium ion or a group -COR<3> <IMAGE>  -SO2-R<5> <IMAGE>  and -CONR<8>R<9>,  in which   R<3> represents optionally substituted radicals from the series comprising alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, or cycloalkyl, arylalkyl, aryl, hetarylalkyl, hetaryl, aryloxyalkyl and hetaryloxyalkyl, it being possible for each of the seven last-mentioned radicals to be interrupted by one or more hetero atoms; R<4> represents optionally substituted radicals from the series comprising alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl, aryl and arylalkyl; R<5>, R<6> and R<7> independently of one another represent optionally substituted radicals from the series comprising alkyl, alkoxy, alkylthio, alkylamino, dialkylamino, alkenylthio, alkynylthio, cycloalkylthio, aryl, aryloxy and arylthio; R<8> and R<9> independently of one another represent hydrogen or optionally substituted radicals from the series comprising alkyl, alkenyl, alkoxy, cycloalkyl, alkoxyalkyl, aryl or arylalkyl, or together form an optionally substituted alkylene group which can be interrupted by one or more hetero atoms or hetero groups;   L represents oxygen or sulphur; and   M represents oxygen or sulphur,   which can be used as pesticides.t
Patent AU-762749-B2 (AU)
Title: Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
Inventor: MURALI RAMACHANDRAN
IPC: A61K31/431
Filed: 1999-07-01
Granted: 2003-07-03
Abstract: Method of identifying compounds that modulate intermolecular interactions between a target protein, such as ²- lactamase, and a modifier, e.g. a substrate, are disclosed. Pharmaceutical composition comprising compounds that inhibit intermolecular interactions between the target protein and a modifier are disclosed. Methods of treating individual suffering from inflammatory conditions, undesirable immune responses, immunological conditions and bacterial infections are disclosed. 
The drug screening method is based on the identification of an allosteric-like cavity near (15-20 Å), but distinct from the critically active (catalytic) site, which interacts with the modifier.
Patent AU-690439-B2 (AU)
Title: Milking system
Inventor: GEHM LANNY
IPC: A01J5/007
Filed: 1996-02-06
Granted: 1998-04-23
Abstract: The present invention features an improved milking system that provides a precise, delineated transition between the pressure and vacuum phases of a pulsator mechanism. The system features a two-valve control that provides a sharp transition between the alternating air pressure and vacuum that are supplied to a teat cup. One valve of the pulsator mechanism controls the vacuum inlet; the other valve controls the atmospheric air inlet. The electronics actuating the valves alternates the air and vacuum supplied to the pulsator outlet, so that the vacuum and atmospheric air sources are never simultaneously connected to the pulsator outlet.
Patent AU-694031-B2 (AU)
Title: An improved fabric for an architectural covering and method and apparatus of manufacturing same
Inventor: COLSON WENDELL B
IPC: E06B9/266
Filed: 1996-04-24
Granted: 1998-07-09
Abstract: A fabric for use in an architectural covering device includes a plurality of elongated vanes preferably of tubular configuration having a pair of flaps extending longitudinally along the entire length of the vane. A continuous face sheet material has elongated folds at spaced intervals that are secured along the flaps of the vanes so as to pivotally connect the vanes to the face sheet material at predetermined spaced intervals. The fabric is adapted to be supported with an operational system in an architectural opening so that if the vanes are suspended vertically they are slidably movable laterally of the window opening and pivotally movable about vertical longitudinal axes to extend and retract as well as open and close the covering. An apparatus and method for forming the fabric is also disclosed as well as systems for finishing the endmost vanes in the fabric.
Patent AU-704934-B2 (AU)
Title: Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
Inventor: GUILLOUX YANNICK
IPC: A61K48/00
Filed: 1996-05-07
Granted: 1999-05-06
Abstract: New tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as NAG tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as NAG coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigen precursor molecules are described.
Patent AU-640145-B2 (AU)
Title: A novel tumor associated antigen
Inventor: BURNETT KAREN GRAY
IPC: C12N5/09
Filed: 1990-06-26
Granted: 1993-08-19
Abstract: A novel tumor-associated antigen expressed by breast carcinoma is disclosed. The antigen, characterized by monoclonal antibody YBM209, is a protein having molecular weight components in the ranges of about 160,000 to about 175,000, 44,000 to about 46,000, and 29,000 to about 35,000 and the 29,000 to 35,000 molecular weight component having an isoelectric point in the range of about pH 6.3 to about pH 6.9. Antibodies directed against the antigen, methods for their production and diagnostic and therapeutic uses therefor are provided.
Patent AU-669979-B2 (AU)
Title: Hand screw clamp
Inventor: SORENSE JOSEPH A
IPC: F16B2/10
Filed: 1994-05-20
Granted: 1996-06-27
Abstract: A hand screw clamp (10) includes first and second jaws (12,14) and a pair of threaded rods (30), each having a handle (32) for manual rotation. Two first couplers (44) are mounted to the first jaw (12) and coupled to the threaded rods (30), and two releasable couplers (50) are mounted to the second jaw (14) and coupled to the threaded rods (30). The releasable couplers (50) each include a threaded portion (52) engageable with the threaded rods (30) and a slidable portion (54) sized to accommodate sliding movement of the threaded rods (30). A push plate (60) is movably mounted to the second jaw (14) and engaged with both of the releasable couplers (50). This push plate (60) is movable between a first position, in which both of the threaded portions (52) are engaged with the rods (30) and manual rotation of the handles (32) moves the second jaw (14) along the threaded rods (30), and a second position, in which both of the threaded portions (52) are disengaged from the threaded rods (30) and the threaded rods (30) are free to slide past the slidable portions (54) without rotation of the threaded rods (30). <IMAGE>
Patent AU-573460-B2 (AU)
Title: Improvements in and relating to margarine and like fat compositions
Inventor: LEACH WARREN
IPC: A21D2/16
Filed: 1986-11-11
Granted: 1988-06-09
Abstract: The fat content of shortenings, margarine and other plastic emulsion fat products containing substantial amounts of combined polyunsaturated fatty acids, also meets specified melting profile requirements and contains limited amounts of combined saturated and trans fatty acids including palmitic acid.
Patent AU-538362-B2 (AU)
Title: 1-(acylamino-aryloxy)-3-alkylamino propan-2-ols-nitrite compounds
Inventor: KOPPE HERBERT
IPC: C07C253/00
Filed: 1981-04-24
Granted: 1984-08-09
Abstract: This invention relates to compounds of the formula    <IMAGE>  (I) wherein R1 represents a linear or branched alkyl of from 1 to 20 carbon atoms; R2 represents a hydrogen or halogen atom, a linear or branched alkyl or alkoxy of from 1 to 4 carbon atoms, or a divalent group -CH=CH-CH=CH- or -(CH2)n-, in which n is an integer of from 3 to 5, with the free valences bonded in the o-position relative to one another; and R3 represents a linear or branched alkyl of from 3 to 10 carbon atoms, with the provisos that R3 is not tert.butyl when R1 is ethyl or propyl and R2 is a hydrogen atom and that R3 is not isopropyl when R1 is propyl and R2 is a hydrogen atom, or a non-toxic, pharmacologically acceptable acid addition salt thereof. The compounds of Formula I are useful for treatment and prophylaxis of diseases of the coronaries, for the treatment of hypertension, and for treatment of cardiac arrhythmia, particularly tachycardia.
Patent AU-635843-B2 (AU)
Title: Method for rendering a substrate surface antithrombogenic and/or anti-infective
IPC: A61L27/54
Filed: 1991-05-27
Granted: 1993-04-01
Abstract: A shaped medical article of a polymeric substrate is extrusion coated with a composition which includes a bioactive agent dispersed in a matrix polymer. Preferred bioactive agents are temperature sensitive agents which undergo thermal decomposition at a temperature above the processing temperature of the matrix polymer. Preferred matrix polymers have a melting point of about 100 DEG C or lower.
Patent AU-636510-B2 (AU)
Title: Novel vitamin d analogues
IPC: A61K31/59
Filed: 1991-07-11
Granted: 1993-04-29
Abstract: Vitamin D derivs. of formula (I) are new. In (I) X = H or OH, R1 and R2 = H, 1-6C hydrocarbyl, or together with C (asterisk) bearing the X gp. can form a 3-8C carbocyclic ring; Q = single bond or 1-8C hydrocarbylene diradical; Hydrocarbylene = residue after removal of 1 or 2H from hydrocarbon; m = 0, 1 or 2. R1, R2 Q opt. substd. with deuterium or F; C(.) atom opt. substd. by deuterium, F or 1-2C alkyl gp. and derivs. of (I) where OH gp. are O-acyl, O-glycosyl gp. f or phosphate ester, or masked gp. hydrolysable in-vivo. Also described 1(S),3(R)-bis-tert-butyldimethyl silyloxy-2O(R)-2,2-dichlorovinyl-9, 10-seco-pregna-5(E),7(E),10(19)-triene as an intermediate.
Patent AU-653360-B2 (AU)
Title: Novel fibrinogen receptor antagonists
Inventor: EGBERTSON MELISSA S
IPC: C07D263/48
Filed: 1991-09-26
Granted: 1994-09-29
Abstract: A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
Patent AU-558002-B2 (AU)
Title: Enhancement of 1 series pg production using retinol or carotenoids and linolenic acid
Inventor: HORROBIN DAVID FREDERICK
IPC: A23L33/155
Filed: 1982-07-12
Granted: 1987-01-15
Abstract: A composition of an effective amount of (a)  gamma -linolenic acid and/or dihomo- gamma -linolenic acid, optionally in association with linoleic and if desired other fat acids, said acids being used if desired as physiologically functional derivatives thereof, in conjunction with (b) an effective amount of one or more of natural or synthetic carotenoids or retinoids having, or giving rise in the body to compounds having, Vitamin A activity when used in therapy of a condition in which enhancement of 1-series PG production, or more broadly influence of the 1-series/2-series PG balance in the body in favour of 1-series PGs is required.
Patent AU-648370-B2 (AU)
Title: Retractable multiband antenna
Inventor: YARSUNAS GEORGE DOMINIC
IPC: H01Q5/00
Filed: 1991-12-19
Granted: 1994-04-21
Abstract: A retractable motorized multi-band antenna is adapted to receive signals in the AM/FM bands and to receive and transmit signals in a significantly higher frequency band such as that used for cellular telephone. In order to transfer the coaxial input signal to an output coaxial connector (110), a slip ring connector (80,81,102,104), is provided. The slip ring connector is impedance matched to the antenna to create low VSWR at RF frequencies. <IMAGE>   <IMAGE>
Patent AU-750272-B2 (AU)
Title: Method and system of dynamic transformation of encrypted material
Inventor: JIA ZHENG
IPC: H04L9/32
Filed: 1998-09-21
Granted: 2002-07-11
Abstract: The present invention provides a method and system that enables software-on-demand and software subscription services based on a dynamic transformation filter technology. The invention is also useful in the distribution of other electronic material. The apparatus utilized in this invention does not create any intermediate storage of decrypted material that is under the protection of this technology. Instead, the apparatus is implemented as a virtually integral part of the operating system that monitors and "filters" all read, write, and open/execute access to and from the I/O devices, such as a hard drive. As the protected material is being accessed for read, write or open/execute, the transformation filter positions itself in the critical path which is required for loading the material through the low level file system layer to the high level application layer. The material enters the transformation filter in its encrypted state. The transformation filter decrypts the material in real-time as it goes through, and hands over the material in its original state to the upper level operating system component to fulfill the access requests. Because the need for intermediate storage is eliminated, the decrypted material in its original state is only visible to integral parts of the operating system components and not to other system users. As a result, security is significantly improved over prior art systems.
Patent BG-60280-B2 (BG)
Title: Pipe joint
Inventor: HOPPERDIETZEL SIEGFRIED
IPC: F16L21/00
Filed: 1990-08-29
Abstract: The pipe joint finds application mainly for building of pipelines, being laid in the soil, for connecting pipes of artificial material or metal. The joint stands compression loads up to reaching the limit compression loads of the connecting pipes. The pipe joint includes an input end (1) of one of the pipes, said end serving as a patrix and being reduced along its outside diameter through a conic passing part (3) to the light hole of the other pipe, serving as a matrix. To the conic part (3) of the reduced circumference (12), to the real circumference of the pipe (11) is formed in the process of reduction at least one supporting zone (2) with a supporting surface (21) for the front surface of the next pipe.
Patent BG-60597-B2 (BG)
Title: Method for the preparation of thermostable -amylase
Inventor: TONKOVA ALEKSANDRA I
IPC: C12N9/28
Filed: 1991-11-26
Abstract: The method is applied for efficient industrial production of thermostable-amylase required for the manufacture of beer, in the starch and glucose industry and others. The enzymic preparation produced has improved amylase activity and thermostability, and the process is made cheaper. By the method the catabolytic-depressed strain Bacillus licheniformis 1542 is cultivated in fermentation nutritive medium having glucose as a source of carbon and with the absence of starch as a component in the medium.